These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7250177)

  • 1. The pharmacokinetics of single doses of metoclopramide in renal failure.
    Bateman DN; Gokal R; Dodd TR; Blain PG
    Eur J Clin Pharmacol; 1981; 19(6):437-41. PubMed ID: 7250177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of metoclopramide.
    Bateman DN
    Clin Pharmacokinet; 1983; 8(6):523-9. PubMed ID: 6360466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of metoclopramide in man with observations in the dog.
    Bateman DN; Kahn C; Davies DS
    Br J Clin Pharmacol; 1980 Apr; 9(4):371-7. PubMed ID: 7378253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral bioavailability of high-dose metoclopramide.
    Taylor WB; Bateman DN
    Eur J Clin Pharmacol; 1986; 31(1):41-4. PubMed ID: 3780825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metoclopramide kinetics in patients with impaired renal function and clearance by hemodialysis.
    Lehmann CR; Heironimus JD; Collins CB; O'Neil TJ; Pierson WP; Crowe JT; Melikian AP; Wright GJ
    Clin Pharmacol Ther; 1985 Mar; 37(3):284-9. PubMed ID: 3971652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure.
    Rey E; d'Athis P; Richard MO; Fillastre JP; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):648-52. PubMed ID: 6526539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of high dose metoclopramide in patients with neoplastic disease.
    Bryson SM; McGovern EM; Kelman AW; White K; Addis GJ; Whiting B
    Br J Clin Pharmacol; 1985 Jun; 19(6):757-66. PubMed ID: 4027119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose pharmacokinetics of metoclopramide.
    Ross-Lee LM; Eadie MJ; Hooper WD; Bochner F
    Eur J Clin Pharmacol; 1981; 20(6):465-71. PubMed ID: 7286058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability and kinetics of cibenzoline in patients with normal and impaired renal function.
    Aronoff G; Brier M; Mayer ML; Barbalas M; Aogaichi K; Sloan R; Brazzell R; Massarella J
    J Clin Pharmacol; 1991 Jan; 31(1):38-44. PubMed ID: 2045527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of high-dose metoclopramide in cancer patients.
    McGovern EM; Grevel J; Bryson SM
    Clin Pharmacokinet; 1986; 11(6):415-24. PubMed ID: 3542335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of haemodialysis on metoclopramide kinetics in patients with severe renal failure.
    Wright MR; Axelson JE; Rurak DW; McErlane B; McMorland GH; Ongley RC; Tam YK; Price JD
    Br J Clin Pharmacol; 1988 Oct; 26(4):474-7. PubMed ID: 3190998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
    Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B
    Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics, bioequivalence and bioavailability of different formulations of metoclopramide in man.
    Block W; Pingoud A; Khan M; Kjellerup P
    Arzneimittelforschung; 1981; 31(6):1041-5. PubMed ID: 7196237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.
    Erikson LO; Wåhlin-Boll E; Odar-Cederlöf I; Lindholm L; Melander A
    Eur J Clin Pharmacol; 1989; 36(2):165-74. PubMed ID: 2721541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and disposition of metoclopramide after single- and multiple-dose administration in diabetic patients with gastroparesis.
    O'Connell ME; Awni WM; Goodman M; Cass O; Melikian AP; Wright GJ; Matzke GR
    J Clin Pharmacol; 1987 Aug; 27(8):610-4. PubMed ID: 3655009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M
    J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and bioavailability of the anti-emetic agent bromopride.
    Brodie RR; Chasseaud LF; Darragh A; Lambe RF; Rooney L; Taylor T
    Biopharm Drug Dispos; 1986; 7(3):215-22. PubMed ID: 3730521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodialysis removal of propafenone.
    Burgess ED; Duff HJ
    Pharmacotherapy; 1989; 9(5):331-3. PubMed ID: 2813154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of verapamil in patients with renal failure.
    Mooy J; Schols M; v Baak M; v Hooff M; Muytjens A; Rahn KH
    Eur J Clin Pharmacol; 1985; 28(4):405-10. PubMed ID: 4029246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic comparison of intranasal, oral, and intramuscular metoclopramide in healthy volunteers.
    Citron ML; Reynolds JR; Kalra J; Kay BG; Nathan KA; Jaffe ND; Miller FR
    Cancer Treat Rep; 1987 Mar; 71(3):317-9. PubMed ID: 3815397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.